The fund will address areas such as import substitution, export growth and human capital development, providing capital to high-growth companies with the potential to grow into market leaders, and in some occasions expand into regional markets. This will support job creation in North Africa, where youth unemployment stands at twice the global average.
Environmental and social aspects
We continue to support the fund manager in the implementation of its robust Environmental and Social Management System (ESMS), particularly in managing specific risks associated with this sector
Since 2012, we’ve only invested in Africa and South Asia. Investments outside these regions are from our pre-2012 portfolio.
- Africa, North Africa
- Investment type
We provide capital in three broad ways: direct equity, debt, and intermediated equity (principally through investment funds).
- Intermediated investment
- Fund manager:
- SPE Capital
- Start date
For direct investments, this is the date CDC committed capital to the business or project.
For funds, this is the date that CDC committed capital to the fund.
For underlying fund investments, this is the date that the fund invested capital into the business.e
- February 2019
For direct investments, this is the total amount that CDC has committed to the business or project (it may be a combination of equity and debt).
For funds, this is the total amount that CDC has committed to the fund.
This is the investee company’s place of incorporation; or a fund’s jurisdiction.
Investments made by this fund
|Investment name||Country||Region||Sector||Start date||Status|
| Future Pharmaceuticals Industries|
Future Pharmaceutical Industries is a national Egyptian Pharma company established to be a unique business in Egypt.
|Holged Tunisie||Africa, North Africa||Active|